CMIG4:BMFBOVESPACompanhia Energetica de Minas Gerais SA Pfd Analysis
Data as of 2026-09-04 - not real-time
R$11.18
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
At BRL 11.18, Companhia Energética de Minas Gerais - CEMIG shows a bearish moving-average alignment, with shorter averages beneath longer ones. Relative strength is 64.8 — approaching overbought — and the MACD signal is bullish. Watch BRL 9.87 as support and BRL 11.31 as the nearer resistance level.
Multiples put this in undervalued territory: 6.9 times earnings against the sector's 19.4. Sell-side targets cluster 10.3% above the current quote. Revenue is growing at 3.4% on a 10.5% profit margin. The 11.46% dividend yield looks stretched against payout coverage.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 25.3%, a beta of 0.37 and a maximum drawdown of 28.0%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 4 out of 10.
Multiples put this in undervalued territory: 6.9 times earnings against the sector's 19.4. Sell-side targets cluster 10.3% above the current quote. Revenue is growing at 3.4% on a 10.5% profit margin. The 11.46% dividend yield looks stretched against payout coverage.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 25.3%, a beta of 0.37 and a maximum drawdown of 28.0%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 4 out of 10.
Top Market Events
Companhia Energética de Minas Gerais - CEMIG CIG is scheduled to announce Q2 earnings results on Thursday, August...Seeking Alpha20dCompanhia Energética de Minas Gerais - CEMIG CIG Q2 2026 Earnings Call TranscriptGood morning,...Seeking Alpha20dCompanhia Energética de Minas Gerais - CEMIG 2026 Q2 - Results - Earnings Call PresentationThe...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 11.44
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 6.9 versus sector average of 19.4
- Dividend yield of 11.46% looks stretched against payout coverage
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- P/E of 6.9 versus sector average of 19.4
- Dividend yield of 11.46% looks stretched against payout coverage
- Analyst targets imply +10.3% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth3.40%
Profit Margin10.51%
P/E Ratio6.9
ROE15.94%
ROA5.94%
Debt/Equity77.95
P/B Ratio1.1
Op. Cash FlowR$3.4B
Free Cash FlowR$-3181103360
Industry P/E19.4
Technical Analysis
TrendBearish
RSI64.8
SupportR$9.87
ResistanceR$11.31
MA 20R$10.48
MA 50R$10.84
MA 200R$11.44
MACDBullish
VolumeDecreasing
Fear & Greed Index96.05
Valuation
Fair ValueR$5.30
Target PriceR$12.33
Upside/Downside10.25%
GradeUndervalued
TypeValue
Dividend Yield11.46%
Risk Assessment
Beta0.37
Volatility25.31%
Sector RiskLow
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.